Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
HAUMANN BRETT K
Chief Medical Officer at Theravance Biopharma. Filing since 19 Aug 2016.
CIK 0001607733
Company
Date
Role
Action
Shares
Amount
Of holding
TBPH
Theravance Biopharma, Inc.
21 Aug 2020
Chief Medical Officer
Sold, plan not stated
25,000
$457.24K
8.1%
TBPH
Theravance Biopharma, Inc.
7 Mar 2017
SVP Clin Dev & Chief Med Ofc
Sold, plan not stated
424
$13.06K
0.3%
TBPH
Theravance Biopharma, Inc.
6 Mar 2017
SVP Clin Dev & Chief Med Ofc
Sold, plan not stated
13,576
$427.92K
7.6%
TBPH
Theravance Biopharma, Inc.
25 Aug 2016
SVP Clin Dev & Chief Med Ofc
Sold, plan not stated
4,491
$125.70K
2.3%
TBPH
Theravance Biopharma, Inc.
19 Aug 2016
SVP Clin Dev & Chief Med Ofc
Sold, plan not stated
9,509
$265.97K
4.6%
5 decisions on file.
